CAS 1377239-83-2

4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-1-piperazinyl]-8-nitro-6-(trifluoromethyl)-

CAS : 1377239-83-2

Formule : C₂₀H₂₃F₃N₄O₃S

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 456.4818

Ref: IN-DA0013RR

2-(4-(Cyclohexylmethyl)Piperazin-1-Yl)-8-Nitro-6-(Trifluoromethyl)-4H-Benzo[E][1,3]Thiazin-4-One

CAS : 1377239-83-2

2-(4-(Cyclohexylmethyl)Piperazin-1-Yl)-8-Nitro-6-(Trifluoromethyl)-4H-Benzo[E][1,3]Thiazin-4-One

Degré de pureté : 97%

Masse moléculaire : 456.48g/mol

Ref: 54-PC108663

Macozinone

CAS : 1377239-83-2

Macozinone

Degré de pureté : ≥98%

Masse moléculaire : 456.48g/mol

Ref: 54-BUP14186

Macozinone

CAS : 1377239-83-2

Macozinone (PBTZ169) inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043.

Formule : C₂₀H₂₃F₃N₄O₃S

Degré de pureté : 99.5% - 99.74%

Couleur et forme : Solid

Masse moléculaire : 456.48

Ref: TM-T3583

PBTZ169

CAS : 1377239-83-2

PBTZ169 is a new drug that is being developed for the treatment of tuberculosis. It inhibits the growth of corynebacterium glutamicum, which has been shown to be resistant to many other drugs. PBTZ169 binds to the hepg2 cell and inhibits the production of ATP in these cells. This binding prevents the formation of ATP-inhibitor complexes with phospholipid membrane enzymes, leading to cell death. PBTZ169 also demonstrates synergistic effects when combined with nitrofurantoin or rifampin antibiotic combinations.

Formule : C₂₀H₂₃F₃N₄O₃S

Degré de pureté : Min. 95%

Masse moléculaire : 456.48 g/mol

Ref: 3D-CFC23983